...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Anthranilic acid based CCK1 antagonists: the 2-indole moiety may represent a 'needle' according to the recent homonymous concept.
【24h】

Anthranilic acid based CCK1 antagonists: the 2-indole moiety may represent a 'needle' according to the recent homonymous concept.

机译:基于邻氨基苯甲酸的CCK1拮抗剂:根据最近的同义概念,2-吲哚部分可能代表“针头”。

获取原文
获取原文并翻译 | 示例
           

摘要

Recently we described an innovative class of non-peptide CCK(1) antagonists keeping appropriate pharmacophoric groups on the anthranilic acid employed as a molecular scaffold. The lead compound obtained, VL-0395, characterized by the presence of Phe and the 2-indole moiety at the C- and N-termini of anthranilic acid, respectively, is endowed with submicromolar affinity towards CCK(1) receptors. Thus, we have prepared and tested on CCK receptors a library of VL-0395 analogues in order to investigate the precise topological and essential key interactions of the 2-indole group of the lead with the CCK(1) receptor. The obtained results confirm that this group establishes very specific interactions with this receptor sub-site and may be viewed as a "needle" group.
机译:最近,我们描述了一类创新的非肽类CCK(1)拮抗剂,在邻氨基苯甲酸上保留了适当的药效基团作为分子支架。获得的铅化合物VL-0395的特征是分别在邻氨基苯甲酸的C-和N-末端存在Phe和2-吲哚部分,并具有对CCK(1)受体的亚微摩尔亲和力。因此,我们已经准备好并在CCK受体上测试VL-0395类似物的文库,以研究铅的2吲哚基与CCK(1)受体的精确拓扑和必要的关键相互作用。获得的结果证实了该组与该受体亚位点建立了非常特定的相互作用,并且可以被视为“针”组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号